Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Rating
Fund
Time to Invest
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
NAV
14.15
(28/11/2022)
L 52Wk H
13.44
16.71
Login using to know what your Friends are Investing !

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Fund
NAV
14.15
(28/11/2022)
Time to Invest
Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment
Rating
L 52Wk H
13.44
16.71

Asset Allocation for Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Top 10 Holdings of Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

67.89 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(16.48%)
Cipla LimitedCipla Limited(9.88%)
Dr. Reddys Laboratories LimitedDr. Reddys Laboratories Limited(8.17%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(7.85%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(5.85%)
Fortis Healthcare LimitedFortis Healthcare Limited(4.30%)
Divi's Laboratories LimitedDivi's Laboratories Limited(4.29%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(4.19%)
Alkem Laboratories LimitedAlkem Laboratories Limited(3.49%)
Lupin LimitedLupin Limited(3.39%)

Detailed Portfolio of Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Portfolio Date -31 Oct 2022
Equity Holdings -28
Other Holdings -2
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 16.48% 80.585 Cr
Cipla Limited 9.88% 48.312 Cr
Dr. Reddys Laboratories Limited 8.17% 39.945 Cr
Apollo Hospitals Enterprise Limited 7.85% 38.370 Cr
Torrent Pharmaceuticals Limited 5.85% 28.589 Cr
Fortis Healthcare Limited 4.30% 21.019 Cr
Divi's Laboratories Limited 4.29% 20.993 Cr
Aurobindo Pharma Limited 4.19% 20.463 Cr
Alkem Laboratories Limited 3.49% 17.049 Cr
Lupin Limited 3.39% 16.566 Cr
J.B. Chemicals & Pharmaceuticals Limited 2.76% 13.473 Cr
Ajanta Pharmaceuticals Limited 2.55% 12.441 Cr
Indoco Remedies Limited 2.35% 11.477 Cr
Eris Lifesciences Limited 2.14% 10.444 Cr
Abbott India Limited 2.04% 9.982 Cr
Sanofi India Limited 1.92% 9.397 Cr
Strides Pharma Science Limited 1.92% 9.393 Cr
Gland Pharma Limited 1.92% 9.389 Cr
IPCA Laboratories Limited 1.81% 8.834 Cr -
Zydus Wellness Limited 1.73% 8.464 Cr
Natco Pharma Limited 1.23% 6.008 Cr
METROPOLIS HEALTHCARE LIMITED 1.18% 5.788 Cr
Medplus Health Services Limited 1.14% 5.556 Cr -
Vijaya Diagnostic Centre Limited 1.08% 5.273 Cr -
Biocon Limited 1.01% 4.929 Cr
Granules India Limited 0.99% 4.845 Cr
Tarsons Products Limited 0.93% 4.548 Cr -
Solara Active Pharma Sciences Limited 0.18% 0.868 Cr
Holdings % Weight Value Sahi Hai/Nahi
Clearing Corporation of India Limited 2.12% 10.370 Cr -
Net Receivables / (Payables) 1.13% 5.532 Cr -

Insight on the composition of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Style Box of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment

Portfolio Characteristics of the Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment Fund Growth

Aditya Birla Sunlife Life Pharma And Healthcare Fund Normal Idcw Reinvestment